Relaxant effects of β-adrenergic agonists on porcine and human detrusor muscle

Acta Physiologica Scandinavica

Volumn 185, Issue 2, 2005, Pages 151-159

  Badawi, J K ^a   Uecelehan, H ^a   Hatzinger, M ^a   Michel, M S ^a   Haferkamp, A ^b   Bross, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Beta adrenoceptor; Beta agonist; Catecholamines; Detrusor relaxation; Human; Organ bath; Pig; Smooth muscle

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ADRENALIN; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; ISOPRENALINE; NORADRENALIN; POTASSIUM; PROCATEROL; SALBUTAMOL;

ANIMAL TISSUE; ARTICLE; BLADDER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DETRUSOR MUSCLE; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SWINE;

ADRENERGIC BETA-AGONISTS; AGED; ALBUTEROL; ANIMALS; DIOXOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; ETHANOLAMINES; FEMALE; HUMANS; ISOPROTERENOL; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH; NOREPINEPHRINE; PROCATEROL; PROPANOLAMINES; SWINE;

EID: 25844520676     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-201X.2005.01474.x     Document Type: Article

References (22)

1. Andersson, K.E. 2000a. Mode of action of alpha 1-adrenoreceptor antagonists in the treatment of lower urinary tract symptoms. BJU Int 85 (Suppl. 2), 12-18.
2. Andersson, K.E. 2000b. Drug therapy for urinary incontinence. Baillieres Best Pract Res Clin Obstet Gynaecol 14, 291-313.
3. Emorine, L.J., Marullo, S., Briend-Sutren, M.M. et al. 1989. Molecular characterization of the human beta 3-adrenergic receptor. Science 245, 1118-1121.
4. Goepel, M., Wittmann, A., Ruebben, H. & Michel, M.C. 1997. Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate. Urol Res 25, 199-206.
5. Grueneberger, A. 1984. Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride. Br J Obstet Gynaecol 91, 275-278.
6. Grueneberger, A. & Geier, G. 1981. Die Therapie der motorischen Reizblase mit dem beta 2-Sympathomimetikum Clenbuterol. Urologe A 20, 153-154.
7. Hu, T. 2004. Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology 63, 461-465.
8. Igawa, Y., Yamazaki, Y., Takeda, H. et al. 1999. Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle. Br J Pharmacol 126, 819-825.
9. Igawa, Y., Yamazaki, Y., Takeda, H. et al. 2001. Relaxant effects of isoproterenol and selective beta3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders. J Urol 165, 240-244.
10. Kaumann, A.J. 1996. CGP12177-induced increase of human atrial contraction through a putative third β-adrenoceptor. Br J Pharmacol 117, 93-98.
11. Lands, A.M., Arnold, A., McAuliff, J.P., Luduena, F.P. & Brown, T.G. Jr 1967. Differentiation of receptor systems activated by sympathomimetic amines. Nature 214, 597-598.
12. Larsen, J.J. 1979. Alpha and beta-adrenoceptors in the detrusor muscle and bladder base of the pig and beta-adrenoceptors in the detrusor muscle of man. Br J Pharmacol 65, 215-222.
13. Longhurst, P.A. & Levendusky, M. 1999. Pharmacological characterization of beta-adrenoceptors mediating relaxation of the rat urinary bladder in vitro. Br J Pharmacol 127, 1744-1750.
14. Longhurst, P.A. & Uvelius, B. 2001. Pharmacological techniques for the in vitro study of the urinary bladder. J Pharmacol Toxicol Methods 45, 91-108.
15. Restorick, J.M. & Mundy, A.R. 1989. The density of cholinergic and alpha and beta adrenergic receptors in the normal and hyper-reflexic human detrusor. Br J Urol 63, 32-35.
16. Sellers, D.J., Yamanishi, T., Chapple, C.R., Couldwell, C., Yasuda, K. & Chess-Williams, R. 2000. M3 muscarinic receptors but not M2 mediate contraction of the porcine detrusor muscle in vitro. J Auton Pharmacol 20, 171-176.
17. Takeda, M., Obara, K., Mizusawa, T. et al. 1999. Evidence for beta3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods. J Pharmacol Exp Ther 288, 1367-1373.
18. Takeda, H., Yamazaki, Y., Akahane, M. et al. 2002. Characterization of beta-adrenoceptor subtype in bladder smooth muscle in cynomolgus monkey. Jpn J Pharmacol 88, 108-113.
19. Takeda, H., Matsuzawa, A., Igawa, Y. et al. 2003. Functional characterization of beta-adrenoceptor subtypes in the canine and rat lower urinary tract. J Urol 170(2 Pt 1), 654-658.
20. Yamanishi, T., Chapple, C.R., Yasuda, K., Yoshida, K. & Chess-Williams, R. 2002. The role of beta(3)-adrenoceptors in mediating relaxation of porcine detrusor muscle. Br J Pharmacol 135, 129-134.
21. Yamazaki, Y., Takeda, H., Akahane, M., Igawa, Y., Nishizawa, O. & Ajisawa, Y. 1998. Species differences in the distribution of beta-adrenoceptor subtypes in bladder smooth muscle. Br J Pharmacol 124, 593-599.
22. Yarker, Y.E., Goa, K.L. & Fitton, A. 1995. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs Aging 6, 243-262.